VRK1, active, GST étiqueté humain, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9, >= 70% (SDS-PAGE), solution aqueuse tamponnée de glycérol

Code: srp5217-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

VRK1 is a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. VRK1 is widely expressed in human tissues and actively d...


en savoir plus

Votre prix
$564.93 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

VRK1 is a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. VRK1 is widely expressed in human tissues and actively dividing cells, such as those in testis, leukocytes, fetal liver and carcinomas. VRK1 regulate cell proliferation and phosphorylates histone, casein, and the transcription factors ATF2 (activating transcription factor 2) and c-JUN. The spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... VRK1(7443)
mol wt~71 kDa
NCBI accession no.NM_003384
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity1.7-2.3 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: